UnknownNot Applicable

Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation

France400 participantsStarted 2018-03-02

Plain-language summary

The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.

Who can participate

Age range18 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>18 ans * inclusion criteria: moderate or severe tricuspid regurgitation * exclusion criteria: Refusal to participate/ prior surgery of the tricuspid valve

What they're measuring

Overall survival

Timeframe: 5 Years

Trial details

NCT IDNCT03546231

SponsorCentre Hospitalier Universitaire, Amiens

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07

Contact for this trial

Christophe TRIBOUILLOY, Pr

03 22 45 58 85 Tribouilloy.Christophe@chu-amiens.fr

View on ClinicalTrials.gov More Tricuspid Valve Disease trials